Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 0 | 0 | 15,58 € | 24,13 € | 54,90 % |
| Celldex Therapeutics | 16 | 1 | 3 | 0 | 36,40 € | 61,99 € | 70,30 % |
| EyePoint Pharmaceuticals Inc. | 38 | 1 | 19 | 0 | 9,48 € | 23,32 € | 146,04 % |
| Omeros Corp. | 2 | 4 | 0 | 0 | 4,54 € | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | 47,60 € | - | - |
| Savara Inc. | 2 | 0 | 1 | 0 | 4,52 € | 5,00 € | 10,62 % |
| Prothena Corp. plc | 13 | 0 | 0 | 0 | 20,60 € | 80,10 € | 288,83 % |
| Enanta Pharmaceuticals Inc. | 6 | 4 | 0 | 0 | 14,60 € | 25,58 € | 75,19 % |
| Puma Biotechnology Inc. | 2 | 0 | 2 | 0 | 3,62 € | - | - |
| Rockwell Medical Inc. | 1 | 0 | 0 | 0 | 1,87 € | 3,00 € | 60,26 % |
| Johnson & Johnson | 57 | 2 | 24 | 1 | 138,52 € | 163,24 € | 17,85 % |
| Aldeyra Therapeutics Inc. | 20 | 1 | 18 | 1 | 3,94 € | 5,50 € | 39,59 % |
| Insmed Inc. | 42 | 1 | 12 | 1 | 70,50 € | 77,06 € | 9,31 % |
| Eli Lilly Corp. | 82 | 1 | 32 | 1 | 864,20 € | 900,00 € | 4,14 % |
| Eledon Pharmaceuticals Inc. | 13 | 1 | 7 | 1 | 2,34 € | 4,00 € | 70,94 % |
| Madrigal Pharmaceuticals inc. | 13 | 1 | 10 | 1 | 251,00 € | 310,00 € | 23,51 % |
| Incyte Corp. | 12 | 3 | 0 | 1 | 58,72 € | 77,67 € | 32,27 % |
| Ani Pharmaceuticals Inc. | 18 | 1 | 18 | 1 | 58,00 € | 69,75 € | 20,26 % |
| PTC Therapeutics Inc. | 15 | 9 | 2 | 1 | 30,60 € | 41,51 € | 35,66 % |
| Agios Pharmaceuticals Inc. | 8 | 1 | 1 | 1 | 44,20 € | 48,75 € | 10,29 % |
| Achieve Life Sciences Inc. | 11 | 1 | 11 | 1 | 4,46 € | 6,50 € | 45,90 % |
| Avid Bioservices Inc | 12 | 1 | 10 | 1 | 7,60 € | 9,10 € | 19,74 % |
| Ardelyx Inc. | 2 | 1 | 1 | 1 | 5,70 € | 11,00 € | 92,91 % |